Hamasy, A., Wang, Q., Blomberg, K. E. M., Mohammad, D. K., Yu, L., Vihinen, M., . . . Smith, C. I. E. (2017). Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant. Leukemia.
Citação norma ChicagoHamasy, A., Q. Wang, K E M. Blomberg, D K. Mohammad, L. Yu, M. Vihinen, A. Berglöf, and C I E. Smith. "Substitution Scanning Identifies a Novel, Catalytically Active Ibrutinib-resistant BTK Cysteine 481 to Threonine (C481T) Variant." Leukemia 2017.
MLA引文Hamasy, A., et al. "Substitution Scanning Identifies a Novel, Catalytically Active Ibrutinib-resistant BTK Cysteine 481 to Threonine (C481T) Variant." Leukemia 2017.
警告:這些引文格式不一定是100%准確.